The overall goal of the Moffitt Cancer Center (MCC) Health Outcomes and Behavior (HOB) Program is to contribute to the prevention, detection, and control of cancer through the study of health-related behaviors, health care practices, and health-related quality of life. Work toward this goal involves research across the disease spectrum ? from prevention and detection through to survivorship or advanced disease. To accomplish its goal, the Program's Specific Aims are: (1) Understand the determinants of behaviors that can lead to prevention and early detection of cancer and develop effective methods of promoting those behaviors; (2) Understand and improve the quality of life of patients and family members throughout the disease course; (3) Contribute to the evidence base, and synthesis of evidence, regarding delivery of cancer care and clinical outcomes; and (4) Understand and intervene upon the social, cultural, and behavioral determinants of cancer- related health disparities. The program comprises 27 members [20 MCC faculty; seven University of South Florida (USF) faculty] from 12 different academic departments (six MCC and six USF). During the reporting period, 547 cancer-related articles have been published, with 218 (40%) representing intra-programmatic collaborations and 135 (25%) representing inter-programmatic collaborations. Inter-institutional collaborations with other NCI-designated Cancer Centers represent 164 (30%) of the publications. Total grant funding for the program currently is $9.1 million in annual total costs, of which $7.5 million is peer-reviewed, including $3.0 million from NCI. Program members conduct hypothesis-driven observational and intervention research on the major cancers affecting the catchment area?lung, prostate, breast, colorectal, cervical?with respect to prevention, screening, quality of life, cancer care delivery, and outcomes. Additionally, toward the goal of reducing cancer- related health disparities, program members conduct community-based participatory research in concert with organizations embedded in the catchment area. In collaboration with colleagues from other programs and institutions, translational research by HOB members is driving public health policy and clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA076292-19
Application #
9209829
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
19
Fiscal Year
2017
Total Cost
$31,374
Indirect Cost
$13,133
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
Research Institutes
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Karolak, Aleksandra; Markov, Dmitry A; McCawley, Lisa J et al. (2018) Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues. J R Soc Interface 15:
Liu, Ying; Wang, Hua; Li, Qian et al. (2018) Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study. Radiology 286:298-306
Padron, Eric; Ball, Markus C; Teer, Jamie K et al. (2018) Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes. Blood 131:2402-2405
Verduzco, Daniel; Kuenzi, Brent M; Kinose, Fumi et al. (2018) Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines. Mol Cancer Ther 17:73-83
Lee, Morgan S; Tyson, Dinorah Martinez; Gonzalez, Brian D et al. (2018) Anxiety and depression in Spanish-speaking Latina cancer patients prior to starting chemotherapy. Psychooncology 27:333-338
Correa, John B; Brandon, Karen O; Meltzer, Lauren R et al. (2018) Electronic cigarette use among patients with cancer: Reasons for use, beliefs, and patient-provider communication. Psychooncology 27:1757-1764
Divakaran, Anand; Talluri, Siva K; Ayoub, Alex M et al. (2018) Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor. J Med Chem 61:9316-9334
de Mingo Pulido, Álvaro; Gardner, Alycia; Hiebler, Shandi et al. (2018) TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer. Cancer Cell 33:60-74.e6
Li, Gongbo; Boucher, Justin C; Kotani, Hiroshi et al. (2018) 4-1BB enhancement of CAR T function requires NF-?B and TRAFs. JCI Insight 3:
McIntyre, Jessica; Jiménez, Julio; Rivera, Yonaira M et al. (2018) Comparison of Health Communication Channels for Reaching Hispanics About Biobanking: a Pilot Trial. J Cancer Educ 33:833-841

Showing the most recent 10 out of 1254 publications